The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome

Journal of Clinical Sleep Medicine

Volumn 5, Issue 2, 2009, Pages 145-150

  Wirojanan, Juthamas ^a,b   Jacquemont, Sebastien ^a,c   Diaz, Rafael ^a,d   Bacalman, Susan ^a   Anders, Thomas F ^a,e   Hagerman, Randi J ^a,f   Goodlin Jones, Beth L ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Fragile X syndrome; Melatonin; Sleep problem

Indexed keywords

MELATONIN; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; AROUSAL; ARTICLE; AUTISM; BEDTIME DOSAGE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FRAGILE X SYNDROME; HUMAN; MALE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SLEEP TIME;

EID: 65349169040     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27443     Document Type: Article

References (39)

1. Owens JA, Witmans M. Sleep problems. Curr Probl Pediatr Adolesc Health Care 2004;34:154-79.
2. Hiscock H, Canterford L, Ukoumunne OC, Wake M. Adverse associations of sleep problems in Australian preschoolers: national population study. Pediatrics 2007;119:86-93.
3. Sadeh A, Gruber R, Raviv A. Sleep, neurobehavioral functioning, and behavior problems in school-age children. Child Dev 2002;73:405-17.
4. Quine L. Sleep problems in primary school children: comparison between mainstream and special school children. Child Care Health Dev 2001;27:201-21.
5. Piazza CC, Fisher WW, Kahng SW. Sleep patterns in children and young adults with mental retardation and severe behavior disorders. Dev Med Child Neurol 1996;38:335-44.
6. Richdale AL. Sleep problems in autism: prevalence, cause, and intervention. Dev Med Child Neurol 1999;41:60-6.
7. Gail Williams P, Sears LL, Allard A. Sleep problems in children with autism. J Sleep Res 2004;13:265-8.
8. Wiggs L, Stores G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy. Dev Med Child Neurol 2004;46:372-80.
9. Richdale AL. A descriptive analysis of sleep behaviour in children with fragile X. J Intellect Dev Disabit 2003;28:135-44.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition-Text Revised. Washington, DC: American Psychiatric Association; 2000.
11. Baird G, Simonoff E, Pickles A, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368:210-5.
12. Reddy KS. Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorder. BMC Med Genet 2005;6:3.
13. Irwin SA, Galvez R, Weiler IJ, Beckel-Mitchener A, Greenough WT. Brain structure and functions of FMR1 protein. In: Hagerman RJ, Hagerman PJ, eds. Fragile X Syndrome: Diagnosis, Treatment and Research, 3rd ed. Baltimore, MD: The Johns Hopkins University Press; 2002:192-205.
14. Crawford DC, Meadows KL, Newman JL, et al. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet 2002;110:226-33.
15. Rogers SJ, Wehner DE, Hagerman R. The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr 2001;22:409-17.
16. Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofanction in autistic children. Neuroendocrinol Lett 2000;21:31-4.
17. Gould EL, Loesch DZ, Martin MJ, Hagerman RJ, Armstrong SM, Huggins RM. Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J Med Genet 2000;95:307-15.
18. O'Hare JP, O'Brien IA, Arendt J, et al. Does melatonin deficiency cause the enlarged genitalia of the fragile-X syndrome? Clin Endocrinol (Oxford) 1986;24:327-33.
19. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336: 186-95.
20. Etzioni A, Luboshitzky R, Tiosano D, Ben-Harush M, Goldsher D, Lavie P. Melatonin replacement corrects sleep disturbances in a child with pineal tumor. Neurology 1996;46:261-3.
21. Lehmann ED, Cockerell OC, Rudge P. Somnolence associated with melatonin deficiency after pinealectomy. Lancet 1996;347:323.
22. Miller LJ, McIntosh DN, McGrath J, et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 1999;83:268-79.
23. Hagerman RJ. Medical follow-up and pharmacotherapy. In: Hagerman RJ, Hagerman PJ, eds. Fragile X Syndrome: Diagnosis, Treatment and Research, 3rd ed. Baltimore, MD: The Johns Hopkins University Press; 2002:287-338.
24. Dodge NN, Wilson GA. Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol 2001;16:581-4.
25. Jan JE, Freeman RD, Fast DK. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev Med Child Neurol 1999;41:491-500.
26. Paavonen EJ, Nieminen-von Wendt T, Vanhala R, Aronen ET, von Wendt L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol 2003;13:83-95.
27. Giannotti F, Cortesi F, Cerquiglini A, Bernabei P. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J Autism Dev Disord 2006.
28. Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006;32:585-9.
29. Brunner E, Domhof S, Langer F. Nonparametric Analysis of Longitudinal Data in Factorial Experiments. New York, NY John Wiley & Sons, Inc.; 2002.
30. Hyde M, O'Driscoll DM, Binette S, et al. Validation of actigraphy for determining sleep and wake in children with sleep disordered breathing. J Sleep Res 2007;16:213-6.
31. Sitnick SL, Goodlin-Jones B, Anders TF. The use of actigraphy to study sleep disorders in preschoolers: some concerns about detection of nighttime awakenings. Sleep 2008;31:395-401.
32. Camfield P, Gordon K, Dooley J, Camfield C. Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials. J Child Neurol 1996;11:341-3.
33. Jan JE, Freeman RD. Melatonin therapy for cireadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Dev Med Child Neurol 2004;46:776-82.
34. Murphy DL, Thmarkin L, Sunderland T, Garrick NA, Cohen RM. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl. Psychiatry Res 1986;17:119-27.
35. Stoschitzky K, Sakotnik A, Lercher P, et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999;55:111-5.
36. Monteleone P, Tortorella A, Borriello R, Natale M, Cassandro P, Maj M. Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans. Bio Psychiatry 1997;41:336-41.
37. Weiskop S, Richdale A, Matthews J. Behavioural treatment to reduce sleep problems in children with autism or fragile X syndrome. Dev Med Child Neurol 2005;47:94-104.
38. Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998;351:1254.
39. Molina-Carballo A, Munoz-Hoyos A, Reiter RJ, et al. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. J Pineal Res 1997;23:97-105.